Plaintiff Steve L. files a loss of consortium claim on behalf of his wife, Robin L., in a products liability litigation against Johnson & Johnson. They allege that she had developed ovarian cancer, suffered, and died due to using the company’s baby powder and Shower-to-Shower products.

The ovarian cancer lawsuit against Johnson & Johnson joins a large multidistrict litigation, or MDL, that centers around the allegations that the talc products cause women to allegedly develop ovarian cancer.

According to the ovarian cancer lawsuit against Johnson & Johnson, it was alleged that the deceased plaintiff, a former resident of Dixon, Illinois, was diagnosed with a talcum powder products injury in April 2014. It was iterated that she had begun to use the product in 2001 and had continued to use it through 2015.

Ovarian Cancer Lawsuit Against Johnson & Johnson Facts

According to the ovarian cancer lawsuit against Johnson & Johnson, it’s claimed that the defendant hid the serious adverse complications of women using the company’s Shower-to-Shower product and baby powder for feminine hygiene. These serious health risks include women allegedly developing ovarian cancer as a result.

Women across the nation are known to have used the company’s products to decrease feminine odors and to absorb moisture. It was marketed for such a purpose, in addition to being safe for babies.

The purported contention against Johnson & Johnson is that the products are made of a talc-based material. The talc material is composed of magnesium, oxygen, and silicon. However, although it may be used in several different cosmetic products, reports indicate that it may be linked to ovarian cancer when used for feminine hygiene.

The ovarian cancer lawsuit against Johnson & Johnson accuses the company of having known of the alleged risks involved in using the talc based material, and, moreover, of having known of the correlation in women developing ovarian cancer from talcum powder. They are accused, according to the ovarian cancer lawsuit against Johnson & Johnson, of disregarding such evidences in attempt to increase their sales and revenues.

According to the ovarian cancer lawsuit against Johnson & Johnson, a study had been conducted that suggested the correlation and risk involved between talc and ovarian cancer. This study was conducted in 1971.

The study, published in the Journal of Obstetrics and Gynaecology of the British Commonwealth, and detailed in the ovarian cancer lawsuit against Johnson & Johnson, was conducted by Dr. W.J. Henderson and others in Cardiff, Wales.

Another study cited in the ovarian cancer lawsuit against Johnson & Johnson was conducted in 1982. This study was the first epidemiologic study that was performed on the impact of talcum powder use in women’s genital area.

According to the ovarian cancer lawsuit against Johnson & Johnson the study, conducted by Dr. Daniel Cramer, “found a 92% increased risk in ovarian cancer with women who reported genital talc use.”

The Ovarian Cancer Lawsuit against Johnson & Johnson is Case No. 3:17-cv-05326-FLW-LHG and is part of the Johnson & Johnson talc powder MDL is In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation, MDL No. 16-2738, in U.S. District Court for the District of New Jersey.